BioCardia Inc (BCDA)
2.29
+0.16
(+7.26%)
USD |
NASDAQ |
Nov 22, 15:03
BioCardia Shareholders Equity (Quarterly): 2.753M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.753M |
June 30, 2024 | -1.961M |
March 31, 2024 | -2.275M |
December 31, 2023 | -1.603M |
September 30, 2023 | -0.66M |
June 30, 2023 | 1.635M |
March 31, 2023 | 1.90M |
December 31, 2022 | 4.892M |
September 30, 2022 | 4.097M |
June 30, 2022 | 6.734M |
March 31, 2022 | 7.369M |
December 31, 2021 | 10.38M |
September 30, 2021 | 13.41M |
June 30, 2021 | 15.67M |
March 31, 2021 | 18.56M |
December 31, 2020 | 19.18M |
September 30, 2020 | 4.113M |
June 30, 2020 | 7.291M |
March 31, 2020 | -1.283M |
December 31, 2019 | 2.37M |
September 30, 2019 | 5.194M |
June 30, 2019 | -2.236M |
March 31, 2019 | 0.818M |
December 31, 2018 | 3.792M |
September 30, 2018 | 2.944M |
Date | Value |
---|---|
June 30, 2018 | 5.758M |
March 31, 2018 | 8.207M |
December 31, 2017 | 11.12M |
September 30, 2017 | 13.78M |
June 30, 2017 | 16.08M |
March 31, 2017 | 18.35M |
December 31, 2016 | 20.58M |
September 30, 2016 | 19.15M |
June 30, 2016 | 14.02M |
March 31, 2016 | 13.95M |
December 31, 2015 | 13.87M |
September 30, 2015 | 13.69M |
June 30, 2015 | 13.69M |
March 31, 2015 | 13.62M |
December 31, 2014 | 13.54M |
September 30, 2014 | 13.48M |
June 30, 2014 | 13.44M |
March 31, 2014 | 13.37M |
December 31, 2013 | 13.31M |
September 30, 2013 | 13.30M |
June 30, 2013 | 13.27M |
March 31, 2013 | 13.26M |
December 31, 2012 | 13.29M |
September 30, 2012 | 13.25M |
June 30, 2012 | 12.80M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.275M
Minimum
Mar 2024
19.18M
Maximum
Dec 2020
5.628M
Average
4.105M
Median
Shareholders Equity (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 32.35M |
The Cooper Companies Inc | 7.925B |
Theriva Biologics Inc | 24.64M |
Zevra Therapeutics Inc | 69.77M |
Instil Bio Inc | 176.33M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.267M |
Total Liabilities (Quarterly) | 3.514M |